South Korea’s proportion of hard-core vegetarians has turned out to be a minimal 7.6 percent, with 92.4 percent being non-vegetarians, according to a survey by the Korea Agro-Fisheries & Food Trade Corp. on 5,510 adult respondents.
The survey was delegated by local pollster Global Research based on seven levels of vegetarian practice.
The ‘flexitarians,' or vegetarians who eat meat on occasion, made up 79.7 percent of the population or 333 persons.
The ‘pollos' who eat milk, eggs, fish, and chicken but not beef or pork made up 11% of the population, whereas the 'pescos,' who only consume seafood, comprised 6.2 percent.
In total, flexitarians, pollos, and pescanos accounted for 96.9 percent of the population.
Only 3.1 percent of vegetarians ate no meat of any kind. That's 0.2 percent of all respondents in the poll.
Only 0.7 percent of the group were classified as ‘lacto-ovos,' those who eat only eggs and milk, while 1.4 percent comprised the ‘ovos,' or egg eaters, who do not consume milk.
Of the respondents, 0.5 percent were made up of persons labeled with the term ‘lactos,' who eat fruits, vegetables, and milk, and another 0.5 percent were vegans,' who only consume vegetables and fruits.


Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



